drugset / Trial / NCT01903473

Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)

NCT01903473

Phase 2 Terminated 19 enrolled University of Liege
Non-randomizedParallel-groupOpen-labelPrevention

Summary

The immune system has offensive and defensive capacities. In bone marrow transplantation, offensive cells in the donor grafts may attack host's organs, leading to a complication known as Graft versus Host Disease (GVDH). At present, patients receive steroid treatment to combat this tricky situation. Nevertheless, some patients do not respond to this therapy. Recently, it has been shown that immune system cells having defensive capacities can help in preventing the occurrence of a GVDH. This study aims to evaluate if these protective cells together with a non-standard immunosuppressor can improve the clinical condition and suppress the activity of the offensive cells in the graft.

Timeline

Start
2013-07
Primary completion
2022-09-12
Completion
2022-09-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sirolimus Small molecule 1 mg